Shitara, K., Choi, H. J., Dayyani, F., Kazmi, S., Korakis, I., Moy, R. H., … Park, W. (2025). 2137P ASP2138 monotherapy in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, advanced solid tumors: Phase I/Ib trial. In Annals of Oncology (Vol. 36, pp. S1121–S1121). Elsevier BV. https://doi.org/10.1016/j.annonc.2025.08.2756

Shitara, K., H. J. Choi, F. Dayyani, S. Kazmi, I. Korakis, R. H. Moy, E. M. O’Reilly, et al. “2137P ASP2138 monotherapy in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, advanced solid tumors: Phase I/Ib trial.” In Annals of Oncology, 36:S1121–S1121. Elsevier BV, 2025. https://doi.org/10.1016/j.annonc.2025.08.2756.

Shitara K, Choi HJ, Dayyani F, Kazmi S, Korakis I, Moy RH, et al. 2137P ASP2138 monotherapy in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, advanced solid tumors: Phase I/Ib trial. In: Annals of Oncology. Elsevier BV; 2025. p. S1121–S1121.

Shitara, K., et al. “2137P ASP2138 monotherapy in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, advanced solid tumors: Phase I/Ib trial.” Annals of Oncology, vol. 36, Elsevier BV, 2025, pp. S1121–S1121. Crossref, doi:10.1016/j.annonc.2025.08.2756.

Shitara K, Choi HJ, Dayyani F, Kazmi S, Korakis I, Moy RH, O’Reilly EM, Picozzi VJ, Simonelli M, Smolenschi C, Souders N, Guseva MV, Jessen WJ, Pavese J, Telaranta-Keerie A, Yang J, Bhattacharya S, Ma J, DeVito N, Park W. 2137P ASP2138 monotherapy in patients (pts) with claudin 18 isoform 2 (CLDN18.2)+, advanced solid tumors: Phase I/Ib trial. Annals of Oncology. Elsevier BV; 2025. p. S1121–S1121.